Please enable JavaScript.
Coggle requires JavaScript to display documents.
Psilocybin produces substantial decreases in depression, anxiety in pts…
Psilocybin produces substantial decreases in depression, anxiety in pts with cancer
-
Methods
-
Design
-
-
-
-
-
Assessments at 1. Baseline, 2. On session days, 3. 5 weeks after sessions, 4. 6 months after 2nd session
-
Experimental issues
-
-
-
Sample did not reflect Population demographics (education, race etc)
Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., Cosimano, M. P., & Klinedinst, M. A. (2016). Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. Journal of Psychopharmacology, 30(12), 1181–1197. https://doi.org/10.1177/0269881116675513